Prof. Michel Ducreux

Go Back

Head of GI Oncology

  • Gustave Roussy Cancer Centre
  • location France
Prof. Michel Ducreux has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Programmes developed by Prof. Michel Ducreux

Video

Episode

2

of 4

episode
Oncology 
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy

Episode 2: Patients with advanced HCC not eligible for IO in 1st line

Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon Yoo
Endorsed by
Digestive Cancers Europe
  • clock 15 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Medical Education grant from Bayer
Video

Episode

3

of 4

episode
Oncology 
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy

Episode 3: Overview of 2nd line treatment options in advanced HCC

Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon Yoo
Endorsed by
Digestive Cancers Europe
  • clock 14 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Medical Education grant from Bayer
Video

Episode

4

of 4

episode
Oncology 
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy

Episode 4: Panel Discussion and Summary

Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon Yoo
Endorsed by
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Medical Education grant from Bayer
Video

Episode

1

of 4

episode
Oncology 
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy

Episode 1: Reviewing the outcomes in HCC with 1st line immunotherapy

Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon Yoo
Endorsed by
Digestive Cancers Europe
  • clock 24 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Medical Education grant from Bayer